Mitochondria are involved in a variety of cellular functions, including ATP production, amino acid and lipid biogenesis and breakdown, signalling and apoptosis [1] [2] [3] . Mitochondrial dysfunction has been linked to neurodegenerative diseases, cancer and ageing 4 . Although transcriptional mechanisms that regulate mitochondrial abundance are known 5 , comparatively little is known about how mitochondrial function is regulated. Here we identify the metabolite stearic acid (C18:0) and human transferrin receptor 1 (TFR1; also known as TFRC) as mitochondrial regulators. We elucidate a signalling pathway whereby C18:0 stearoylates TFR1, thereby inhibiting its activation of JNK signalling. This leads to reduced ubiquitination of mitofusin via HUWE1, thereby promoting mitochondrial fusion and function. We find that animal cells are poised to respond to both increases and decreases in C18:0 levels, with increased C18:0 dietary intake boosting mitochondrial fusion in vivo. Intriguingly, dietary C18:0 supplementation can counteract the mitochondrial dysfunction caused by genetic defects such as loss of the Parkinson's disease genes Pink or Parkin in Drosophila. This work identifies the metabolite C18:0 as a signalling molecule regulating mitochondrial function in response to diet.
To study the function of very long chain fatty acids, we analysed Drosophila lacking Elovl6 (refs 6, 7), the enzyme elongating C16 fatty acids to C18. Sequence analysis identified noa 8 as fly Elovl6 (herein referred to as Elovl6). On standard laboratory food, Elovl6 loss-of-function animals (l(3)02281 2/2 ; Elovl6 2 ) die as early larvae 8 (Fig. 1a ). We confirmed that Elovl6 2 mutants have impaired C16:0RC18:0 elongase activity and reduced C18:0 levels (Extended Data Fig. 1a, b ), and that their lethality is rescued by human ELOVL6 (Extended Data Fig. 1c, d ). Survival to pupation was rescued by supplementing fly food (containing little lipid), with C18:0 ( Fig. 1a ), but not C18:1 or C20:0 (Extended Data Fig. 1e ), confirming that the larval lethality is due to C18:0 deficit.
We serendipitously discovered that removing antifungal agents from fly food improved survival of Elovl6 2 mutants (Fig. 1a ). Since these agents are mitotoxins, this suggested that Elovl6 2 mutants might be hypersensitive to mitochondrial inhibition. Indeed, sub-lethal concentrations of rotenone, a mitochondrial respiratory chain complex I inhibitor, killed Elovl6 2 mutants when added to antifungal-free food (Fig. 1b ), but other drugs did not (Extended Data Fig. 1f ). Thus, mitochondrial function is limiting in Elovl6 2 mutants. Elovl6 2 mutants have impaired mitochondrial respiration, rescued by dietary C18:0 supplementation (Fig. 1c ) or by expressing an alternative oxidase, AOX 9 , allowing bypass of complexes III and IV (Fig. 1d ). Complex IV activity was not impaired in Elovl6 2 mutants (Extended Data Fig.  1g ), suggesting that Elovl6 2 mutants suffer from a complex III defect.
If the main cause of Elovl6 2 lethality is reduced mitochondrial function, then viability should be rescued by restoring mitochondrial functional capacity. Indeed, Elovl6 2 viability was rescued by expressing AOX or Spargel (Drosophila PGC1A), driving mitochondrial Fig. 1h , i). Thus, the organismal function of C18:0 is less pleiotropic than expected. Interestingly, Drosophila Elovl6 localizes to mitochondrial outer membranes ( Fig. 1g and Extended Data Fig. 1j ). Lipidomic analysis of purified larval mitochondria (Extended Data Fig. 5b ) revealed that their membranes have little C18:0 (Extended Data Fig. 2a ), suggesting that C18:0 does not have a structural role in mitochondria. Elovl6 2 mutants also did not have fewer mitochondria than controls (assayed by porin levels and citrate synthase activity; Extended Data Fig. 2b , c). We therefore investigated whether C18:0 regulates mitochondrial activity. Mitochondria dynamically fuse and fission to form tubular structures 10, 11 . Elovl6 2 mutants had hyperfragmented mitochondria, rescued by dietary C18:0 supplementation ( Fig. 2a and Extended Data Fig. 2d ). Elovl6 knockdown in S2 cells reproduced this phenotype (Fig. 2b ), indicating that it is cell autonomous. Importantly, we grow S2 cells in serum-free medium, which lacks fatty acids normally bound to bovine serum albumin (BSA) in serum. Mitochondria of Elovl6-knockdown cells rapidly re-fused upon addition of BSA-conjugated C18:0 to the medium for just 120 min ( Fig. 2b ) or 20 min (data not shown). Mitochondria of HeLa cells also fragmented when grown in medium with serum that was delipidated by organic extraction (Fig. 2c ). This was rescued by re-adding BSA-conjugated C18:0 for 2 h (Fig. 2c ), but not other fatty acids (Extended Data Fig. 2e ). One lipid specific to mitochondria is lipoic acid. Knockdown of lipoic acid synthase (LIAS) led to reduced lipoic acid levels but not mitochondrial fragmentation (Extended Data Fig. 2f ), and depletion of C18:0 did not affect levels of lipoic acid or lipoylated proteins (Extended Data Fig. 2g , h), indicating that the effects of C18:0 are independent of lipoic acid. Thus, C18:0 regulates mitochondrial morphology in fly and human cells.
Mitochondrial fragmentation is due to either hyperactive fission or impaired fusion. Blocking fission with mdivi-1, a DRP1 inhibitor 12 , induced mitochondrial fusion in control cells, but not in HeLa cells cultured without C18:0 ( Fig. 2d ), indicating impaired mitochondrial fusion in this condition. Mitochondria labelled with photoactivatable mitochondrially targeted green fluorescent protein (mitoGFP) 13 rapidly fused with the rest of the network (stained with MitoTracker Red) in control cells, but not in cells cultured without C18:0, demonstrating impaired fusion ( Fig. 2e ).
Mitochondrial fusion is regulated largely by mitofusins 14, 15 . Epistasis experiments indicated that C18:0 acts upstream of mitofusin to regulate mitochondrial morphology: expression of Drosophila mitofusin (dMfn; also known as Marf) rescued mitochondrial fragmentation in Elovl6-knockdown cells ( Fig. 3a) , indicating that dMfn acts downstream of C18:0. C18:0 did not induce fusion in the absence of dMfn ( Fig. 3b ), indicating that C18:0 requires dMfn for its action. Likewise, expression of dMfn rescued Elovl6 2 larval lethality ( Fig. 3c ). To test whether C18:0 can rescue dMfn loss of function, we generated dMfnknockout flies. These flies phenocopy Elovl6 2 mutants: they have fragmented mitochondria, reduced mitochondrial respiration, and die as early stage larvae that do not grow (Extended Data Fig. 3a-d ).
Dietary supplementation with C18:0 had no effect on the growth or viability of dMfn knockouts ( Fig. 3d ). We asked whether C18:0 affects Mfn via post-translational modifications (PTMs). Mfn from Elovl6 2 mutant larvae, or from HeLa cells growing with delipidated serum, migrated differently in SDSpolyacrylamide gel electrophoresis (SDS-PAGE) compared with control conditions (Extended Data Fig. 3e , f). Immunoprecipitating MFN2 from HeLa cells treated with or without C18:0 and probing with antibodies detecting various PTMs revealed that MFN2 from cells without C18:0 is hyper-ubiquitinated ( Fig. 4d ), identifying HUWE1 as the C18:0-responsive ubiquitin ligase. As expected 19 , increased MFN2 ubiquitination caused MFN2 protein destabilization (Extended Data Fig. 3h ). C18:0 removal did not dramatically drop MFN2 steady-state levels, partly due to compensatory increases in MFN2 expression (Extended Data Fig. 3i ), suggesting that ubiquitination additionally blocks MFN2 function in a degradationindependent manner, as for other HUWE1 targets 20 . HUWE1 only ubiquitinates MFN2 phosphorylated on Ser 27 by JNK 19 . Inhibition of JNK prevented mitochondrial fragmentation upon C18:0 removal ( Fig. 3g ). In sum, C18:0 regulates MFN2 ubiquitination via HUWE1, and thereby mitochondrial morphology and function. Elovl6 2 mutant flies display other dMfn loss-of-function phenotypes, such as reduced endoplasmic-reticulum-mitochondrial connections and abnormal cristae 21, 22 (Extended Data Fig. 5 ).
We asked how C18:0 affects JNK or HUWE1 activity. Endoplasmic reticulum stress can activate JNK. However, C18:0 removal did not lead to an unfolded protein response (UPR) (Extended Data Fig. 6a , b) and neither knockdown of UPR effectors nor treatment with tauroursodeoxycholic acid (TUDCA), an endoplasmic reticulum chaperone that inhibits endoplasmic reticulum stress 23 , blunted mitochondrial fragmentation upon C18:0 removal (Extended Data Fig. 6c, d) . Instead, we hypothesized that C18:0 might regulate proteins via covalent binding ('stearoylation'), analogous to protein palmitoylation. We synthesized C18:0 derivatives with azide or alkyne functionalities, allowing covalent coupling to beads via copper-catalysed azide-alkyne cycloaddition ('click chemistry') (Extended Data Fig. 7b ). We tested multiple derivatives, and only C17:0-azide induced mitochondrial fusion like C18:0 (Extended Data Fig. 7a ). We treated HeLa cells with C17:0-azide for 2 h, lysed them in 8 M urea to denature proteins, precipitated the lipid by coupling to beads, and identified covalently bound proteins by mass spectrometry. The most abundant protein in the lipid pulldown was TFR1 (Extended Data Fig. 7b, right) , confirmed by immunoblotting (Extended Data Fig. 7c, lanes 1-3) . Binding of TFR1 to C17:0-azide was abolished by treating lysates with hydroxylamine pH 7.5, indicating a thioester linkage (data not shown). We tested the top ten putatively stearoylated protein complexes for effects on mitochondrial morphology by knockdown. Knockdown of TFR1 completely blunted mitochondrial fragmentation upon C18:0 removal ( Fig. 3h and Extended Data Fig. 7b, right, d) . Thus, TFR1 is required for cells to sense the absence of C18:0. Since TFR1 is important for cellular iron uptake, TFR1 stearoylation could affect mitochondria via iron uptake or delivery. However, cells grow for days in medium lacking C18:0 but die in medium lacking iron (Extended Data Fig. 8a ), suggesting that iron uptake is not markedly impaired in the absence of C18:0. Indeed, cells in medium lacking C18:0 do not show an iron deficiency transcriptional response (Extended Data Fig. 8b ), a drop in protein or activity levels of enzymes containing iron-sulfur clusters (Extended Data Fig. 8c-f ), impaired transferrin uptake (Extended Data Fig. 8g ), or reduced association of transferrin with mitochondria (Extended Data Fig. 8h ), suggesting that the effects of C18:0 are independent of iron. TFR1 also has a signalling function, activating JNK in response to the ligand gambogic acid 24 . Low concentrations of gambogic acid that do not induce apoptosis (Extended Data Fig. 9a ) induced rapid mitochondrial fragmentation in HeLa cells (2 h; Fig. 3i ). This was suppressed by adding C18:0 ( Fig. 3i and Extended Data Fig. 9b ), indicating that C18:0 blocks this signalling function of TFR1. Indeed, treatment of HeLa cells with C18:0 reduced JNK activation, using JNK phosphorylation and phospho-JNK nuclear translocation as readouts (Extended Data Fig. 9c, d) . JNK inhibition blocked the ability of gambogic acid to induce mitochondrial fragmentation ( Fig. 3j and Extended Data Fig. 9e ). In sum, these data suggest that TFR1 induces mitochondrial fragmentation via JNK, and that this is inhibited by TFR1 stearoylation (Fig. 3k ).
Palmitoyl-transferases covalently bind C16:0 before transferring it to substrates. We found one member of this family, ZDHHC6, in our C17:0-azide pulldowns, suggesting that it is a C18:0 transferase. Indeed, knockdown of ZDHHC6 blunted TFR1 stearoylation (Extended Data Fig. 7c, lane 5) . Further work is required to study this in detail.
We noticed that elevating C18:0 levels in control cells increases mitochondrial fusion (Fig. 2b) . Supplementing the diet of wild-type flies with C18:0 also increased mitochondrial fusion, whereas starvation of larvae led to mitochondrial fragmentation ( Fig. 4) . Thus, fly cells respond to both increases and decreases in levels of C18:0.
We asked whether dietary C18:0 supplementation could improve mitochondrial function in pathological conditions. Flies mutant for Pink or Parkin are established Parkinson's disease models. They have impaired mitochondrial function, and recapitulate Parkinson's disease phenotypes (reduced lifespan, neurodegeneration and impaired motor control [25] [26] [27] [28] [29] ). Dietary supplementation with C18:0 rescued the longevity, ATP levels and climbing defects of Pink 2 flies and the longevity of Parkin 2 flies ( Fig. 4 and Extended Data Fig. 10 ; other Parkin phenotypes not tested).
We identify C18:0 as a regulator of mitochondrial function. Upon loss of C18:0, TFR1 de-stearoylation activates JNK, leading to HUWE1-dependent MFN2 ubiquitination, impaired MFN2 activity 19 , and mitochondrial fragmentation. Loss of C18:0 in flies specifically impacts mitochondrial function, since Elovl6 2 lethality can be rescued by Spargel, AOX or dMfn expression or Huwe1 knockdown. To our knowledge, this is the first time stearoylation of a human protein has been found to regulate its function. The link between TFR1 and mitochondria perhaps makes sense, because iron enters cells via TFR1 and then mainly travels to mitochondria for iron-sulfur clusters. Flies are sensitive to dietary C18:0; increased dietary C18:0 leads to increased mitochondrial fusion in vivo. Thus, the metabolite C18:0 acts as a signalling molecule linking diet to mitochondrial function. Intriguingly, dietary C18:0 can also improve mitochondrial function in some pathological conditions in the fly, since dietary supplementation with C18:0 improved the Parkinson's-disease-related LETTER RESEARCH phenotypes observed in Pink and Parkin mutant flies (see Supplementary Discussion) .
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Extended Data Figure 1 | noa/Elovl6 is the functional homologue of human ELOVL6. a, C16:0 to C18:0 elongase activity is significantly blunted in Elovl6 mutants, whereas elongase activities on other fatty acids measured are not affected. Microsomal preparations from control or Elovl6 mutant animals were incubated with radioactive malonyl-CoA and the indicated fatty-acyl-CoA. Elongation was quantified by incorporation of the aqueous metabolite malonyl-CoA into lipid-soluble fatty acids, as described previously 30 Oxygen consumption was measured in the presence of only N,N,N9,N9-tetramethyl-p-phenylenediamine dihydrochloride (TMPD) as substrate, which can be directly oxidized by complex IV. The values were corrected for non-mitochondrial oxygen consumption (oxygen consumption in the presence of complex IV inhibitor potassium cyanide (KCN)) and normalized to tissue weight. n 5 3. h, i, Overexpression of Spargel in Elovl6 mutant female pre-wandering larvae leads to increased mitochondrial abundance, assessed by porin levels (h; representative of six biological replicates) and citrate synthase activity (i; n 5 4) in pre-wandering larvae. See Supplementary Fig. 12 for image of the uncropped full western blot. j, Drosophila Elovl6 (either N-or C-terminally tagged) localizes to the mitochondrial outer membrane. S2 cell lysates ('total') were successively fractionated to yield crude mitochondria (which include mitochondrialassociated membranes (MAMs)), pure mitochondria (lacking MAMs), and mitochondrial outer membranes (OM), inner membranes (IM) and intermembrane space (IMS). Endogenous porin and ATPsyn-a were used as positive controls for outer membranes and inner membranes, respectively. 7.5 mg of protein from each fraction was loaded per lane. See Supplementary  Fig. 13 a, Lipidomic (GC-FID) profiles of purified mitochondria from Elovl6 mutant 3rd instar larvae do not show major differences compared with control animals. Mitochondrial membranes from both control and mutant animals have very low levels of C18:0. Controls for purity of mitochondrial prep are shown in Extended Data Fig. 6b . b, c, Elovl6 mutant larvae do not have reduced amounts of mitochondria, quantified via levels of porin (b; representative of three biological replicates) or citrate synthase activity (c; n 5 3). See Supplementary  Fig. 14 for image of the uncropped full western blot. d, Elovl6 mutant larvae have fragmented mitochondria, which is rescued by dietary C18:0 supplementation. Mitochondrial morphology from fat bodies of control or Elovl6 mutant female larvae, fed control or C18:0 (10%) supplemented food, visualized with mitoGFP. Images are representative of eight areas of four larvae from each genotype and food conditions. Equivalent pictures for body wall are shown in Fig. 2a . e, Only C18:0, and not shorter, longer or desaturated fatty acids, restores mitochondrial fragmentation to control levels in HeLa cells grown in medium containing delipidated serum. Mitochondria were visualized with MitoTracker (red) (top) and mitochondrial fragmentation was quantified by normalizing the number of mitochondrial particles to total mitochondrial area (bottom) (n 5 15). f, Reduced lipoic acid (LA) levels do not lead to mitochondrial fragmentation. Lipoic acid synthase (LIAS) was knocked down by RNAi in HeLa cells, leading to significantly reduced lipoic acid levels, assayed by immunoblotting of total cell lysates with antibody detecting lipoic acid (bottom left). Unlike removal of C18:0, this does not lead to mitochondrial fragmentation. Representative images (top left) are quantified (top right) (n 5 6). See Supplementary Fig. 14 for image of the uncropped full western blot. g, h, HeLa cells growing in medium containing delipidated serum do not display reduced levels of protein lipoylation (g) or reduced levels of lipoylated proteins (h). HeLa cells were grown in medium containing delipidated serum for either 24 h (the same time point used for all other experiments in which mitochondrial fragmentation was assessed) (g, h), or for an extended period of time: 4 days (h). Lipoic acid levels were assayed by immunobloting total cell lysates with an anti-lipoic acid antibody (g), and levels of lipoylated proteins were assessed with specific antibodies (h). See Supplementary Fig. 15 for image of the uncropped full western blot.
c, e, f, *P , 0.05, **P , 0.01, not significant (NS) P $ 0.05, two-tailed t-test.
Error bars represent s.d. Scale bars, 10 mm.
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Extended Data Figure 3 | Mitofusin loss of function phenocopies Elovl6 mutation or removal of C18:0. a, dMfn knockout larvae (1st instar) have fragmented mitochondria, visualized with mitoGFP. Representative of ten images. b, Endogenous dMfn runs as a main band plus a laddering of apparently increasing molecular weights on an SDS-PAGE gel. Specificity is controlled by blotting lysates from control and Mfn-knockout female larvae with anti-Mfn antibody. c, Homozygous mutation of dMfn is lethal. Mfnknockout larvae survive for several days as small L1/L2 larvae and eventually die. Synchronized 1st instar larvae were grown on standard fly food and examined every 24 h for developmental stage and per cent survival (n 5 30). d, dMfn-knockout animals have impaired oxygen consumption. Oxygen consumption of inverted, digitonin permeabilized, female larval tissues was measured with an Oroboros oxygraph chamber and normalized to tissue weight. Oxygen consumption was measured in the presence of the following substrates: GMN (glutamate and malate), GMD (glutamate, malate and ADP), GMcD (glutamate, malate, cytochrome c and ADP), GMScD (glutamate, malate, succinate, cytochrome c and ADP), ETS (glutamate, malate, cytochrome c, ADP and uncoupling reagent), and Sc(Rot)u (glutamate, malate, cytochrome c, ADP and rotenone). n 5 5. e, Endogenous dMfn is posttranslationally modified in a C18:0-dependent manner in Drosophila. dMfn from Elovl6 female mutants migrates in an SDS-PAGE gel differently, compared with Mfn2 from control animals. This is reversed by supplementing the diet with C18:0. All indicated bands are dMfn, since they disappear in lysates from dMfn-knockout animals (see Extended Data Fig. 3b ). Flies were grown on antifungal-free food. f, Endogenous MFN2 is post-translationally modified in a C18:0-dependent manner in human HeLa cells. MFN2 immunoprecipitated from HeLa cells treated for 24 h with medium containing standard or delipidated serum, and then for 2 h in the absence or presence of C18:0 (100 mM), lysed in 8M urea (see Methods). g, C18:0 affects ubiquitination of MFN2. MFN2 is more heavily ubiquitinated in cells treated with delipidated serum than in control cells and this is reversed by supplementing the medium with C18. HeLa cells were cotransfected with tagged versions of MFN2 (myc) and ubiquitin (HA). Tagged MFN2 was immunoprecipitated and blots were probed with HA antibody to detect ubiquitination. Quantification of ubiquitination, normalized to Myc-MFN2 in the immunoprecipitate (IP) is shown below the lane. h, C18:0 removal destabilizes MFN2 protein. A cyclohexamide (CHX) chase experiment was performed to block de novo synthesis of MFN2, thereby looking at turnover of existing MFN2 protein in vivo. HeLa cells treated with medium containing delipidated serum plus or minus C18:0 were treated with 100 mM CHX and then lysed at the indicated time points to compare MFN2 protein levels. Bottom, densitometric quantification of the blots normalized to loading control. i, dMfn expression is upregulated in Elovl6 2 flies compared with controls. dMfn transcript levels in 24 h female pre-wandering larvae were determined by quantitative polymerase chain reaction with reverse transcription (RT-PCR), normalized to rp49 (in triplicates). Scale bar, 10 mm. d, i, *P , 0.05, **P , 0.01, ***P , 0.001, not significant (NS) P $ 0.05, two-tailed t-test. Error bars represent s.d. See Supplementary Fig. 16 for images of the uncropped full western blots.
Extended Data Figure 4 | HUWE1 is required for hyperubiquitination of MFN2 in response to C18:0 withdrawal. a, Short interfering RNA (siRNA) depletion of other ubiquitin ligases targeting MFN (besides HUWE1, shown in Fig. 3) does not rescue the mitochondrial fragmentation induced by removal of C18:0 (top). Bottom, quantification. n 5 15. b, siRNA depletion of PARK2 in HEK293 cells, as in HeLa cells (a), does not rescue the mitochondrial fragmentation induced by removal of C18:0 (top). Bottom, quantification. n 5 15. c, HUWE1 knockdown efficiency controlled by detecting HUWE1 protein levels. See Supplementary Fig. 17 
Extended Data Figure 5 | Elovl6 mutants have other Mfn loss-of-function phenotypes such as reduced mitochondrial-associated membranes and abnormal cristae. a, The mitochondrial associated membranes (MAM) band is strongly reduced or absent in Percoll gradients of crude mitochondrial fractions from Elovl6-mutant animals, compared with controls. b, Purity control of mitochondrial preparations show that pure mitochondrial fractions are lacking markers of other subcellular organelles such as calnexin (endoplasmic reticulum) and lamin (nuclei). See Supplementary Fig. 17 
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Extended Data Figure 7 | TFR1 is the mediator of C18:0 signalling to mitochondrial morphology. a, C17:0-azide is a functional analogue of C18:0 in that it induces mitochondrial fusion in HeLa cells, whereas other C18:0 derivatives are not. Cn:0-azide 5 HO 2 C(CH 2 ) n 2 1 N 3 ; Cn:0-alkyne 5 HO 2 C(CH 2 ) n 2 1 CCH. b, TFR1 is the most enriched protein in a C17:0-azide pulldown, and it regulates mitochondrial morphology. HeLa cells were treated with C17:0-azide for 2 h, and covalently bound proteins were precipitated by lysing cells under denaturing conditions (8 M urea), and linking the C17:0azide to an alkyne-labelled resin via click chemistry (left). Precipitated proteins were identified by mass spectrometry, and peptide counts were normalized to peptide counts in a negative control pulldown from cells not treated with C17:0-azide (n 5 3) (right; column 2). Indicated proteins were also tested by siRNA-mediated knockdown for effects on mitochondrial morphology (column 3). c, TFR1 is covalently bound to the C18:0 derivative C17:0-azide in HeLa cells in a ZDHHC6-dependent manner. HeLa cells were treated with C17:0-azide for 2 h, and subsequently lysed in denaturing conditions (8 M urea) . Similar to b, the C17:0-azide was 'clicked' onto a biotinylated alkyne, and the labelled proteins were pulled-down with streptavidin beads. After washing, immunoprecipitated proteins were eluted off beads in Laemmli buffer containing biotin, and analysed by immunoblotting. The palmitic acid analogue C15:0-azide was used as a positive control since TFR1 is known to also be palmitoylated. C17:0-azide pulls down more TFR1 than equal amounts of C15:0-azide, indicating that TFR1 palmitoylation cannot account for the C17:0 signal. The C17:0-azide-TFR1 interaction is completely blunted upon ZDHHC6 knockdown. See Supplementary Fig. 18 for image of the uncropped full western blot. d, TFR1 is required for C18:0 removal to induce mitochondrial fragmentation. HeLa cells were transfected with either control or TFR1 targeting siRNAs before treatment with medium containing delipidated serum plus or minus C18:0. Representative images are shown here and quantification of mitochondrial fragmentation is shown in Fig. 3h . n 5 15.
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Extended Data Figure 9 | JNK signalling is required for mitochondrial fragmentation induced by C18:0 removal. a, Treatment of HeLa cells with 1 mM gambogic acid does not induce apoptosis. 10 mM gambogic acid was used as a positive control for apoptosis induction, assessed by cleaved caspase-3 levels. 1 mM gambogic acid neither induces caspase cleavage (shown here) nor causes cells to die (data not shown). Cells were treated with 10 mM gambogic acid for 1 h, or for all other concentrations for 3 h. See Supplementary  Fig. 20 for image of the uncropped full western blot. b, Activation of TFR1 by treating cells with 1 mM gambogic acid leads to mitochondrial fragmentation that is reversed by 1 h C18:0 pre-treatment. Representative images are shown here and quantification of mitochondrial fragmentation is shown in Fig. 3i (n 5 15) . c, Treatment of HeLa cells with C18:0 to inhibit TFR1 causes reduced JNK signalling activity, assayed by p-JNK levels on an immunoblot. See Supplementary Fig. 20 for image of the uncropped full western blot. d, Removal of C18:0, as well as treatment with gambogic acid, induces shuttling of phosphorylated JNK into the nucleus. Cells were stained with phospho-JNK antibody (left) and relative levels of nuclear to cytosolic phospho-JNK signal was quantified (right) (n 5 37 cells). ***P , 0.001, two-tailed t-test. Error bars show s.d. e, JNK signalling is required for TFR1 activation to induce mitochondrial fragmentation. HeLa cells were treated with the JNK inhibitor SP600125 30 min before gambogic acid treatment to activate TFR1. Representative images are shown here and quantification of mitochondrial fragmentation is shown in Fig. 3j (n 5 15) .
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